Tuesday, March 31, 2015

Top China Companies For 2015

Top China Companies For 2015: Arotech Corporation(ARTX)

Arotech Corporation, together with its subsidiaries, provides defense and security products. It operates in three divisions: Training and Simulation, Battery and Power Systems, and Armor. The Training and Simulation division develops, manufactures, and markets multimedia and interactive digital solutions for use-of-force training and driving training of military, law enforcement, security, and other personnel; provides simulators, systems engineering, and software products to the United States military, government, and private industry; and offers specialized use of force training for police, security personnel, and the military. The Battery and Power Systems division manufactures and sells lithium and zinc-air batteries for defense and security products and other military applications; and develops and sells rechargeable and primary lithium batteries and smart chargers to the military and to private defense industry. This division also develops, manufactures, and markets primary zinc-air batteries, rechargeable batteries, and battery chargers for the military; and produces water-activated lifejacket lights for commercial aviation and marine applications. The Armor Division manufactures military and paramilitary armored vehicles, and employs sophisticated lightweight materials to produce aviation armor; and uses engineering concepts to produce combat armored military vehicles and up-armor civilian commercial vehicles. This division also uses lightweight armoring materials and advanced engineering processes to provide ballistic armor kits for rotary and fixed wing aircraft. Arotech sells its products primarily in the United States, Israel, Taiwan, Canada, England, Germany, Australia, China, Hong Kong, Mexico, India, Spain, Singapore, and Japan. The company was formerly known as Electric Fuel Corporation and changed its name to Arotech Corporation in September 2! 003. Arotech Corporation was founded in 1990 and is based in Ann Arbor, Michigan.

Advisors' Opinion:
  • [By Anna Prior]

    Defense and security-products maker Arotech Corp.(ARTX) said it plans to offer an unspecified amount of its shares in a public offering. Arotech recently had about 21 million shares outstanding, according to FactSet. Shares fell 6.9% to $3.50 premarket.

  • [By Lisa Levin]

    Arotech (NASDAQ: ARTX) declined 5.85% to $3.54 after the company priced 2.86 million share offering at $3.50 per share.

    Radian Group (NYSE: RDN) dropped 5.09% to $13.81 after the company provided a comment on the proposed GSE requirements for private mortgage insurer eligibility.

  • [By Wallace Witkowski]

    Shares of Arotech Corp. (ARTX)  declined 5.6% to $3.55 after the defense and security products maker announced a secondary offering of its shares to pay off debt and other corporate expenses.

  • [By James E. Brumley]

    Well, I can only give myself a C+ for my timing, but I'll still give myself an A for picking 'em. Today, nearly a month after a picked it, Arotech Corporation (NASDAQ:ARTX) shares are finally taking off. If my read on the ARTX is right - the same read I had in mid-May - this is just the beginning of a rewarding rally for the stock.

  • source from Top Stocks For 2015:http://www.topstocksblog.com/top-china-companies-for-2015-2.html

Monday, March 30, 2015

Top 10 Industrial Disributor Stocks To Invest In 2015

Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis.

Despite a slow morning, stocks battled back to finish the day nearly unchanged, as the Dow Jones Industrial Average (DJINDICES: ^DJI  ) closed down 5 points or 0.03%, coming back from a 100-point deficit earlier in the day. The S&P 500 and Nasdaq, meanwhile, lost 0.2% and 0.5%, respectively. The day's economic reports were mostly in line with expectations, as an ISM Services report rated last month's growth in the category at 54.0, indicating a modest expansion, while the ADP's employment report said 175,000 jobs were added in January, even with expectations for the official report due out on Friday. Atlanta Federal Reserve President Dennis Lockhart also said earlier in the day that he expects the stimulus taper to continue in increments of $10 billion as it's begun and that it should be completed by the fourth quarter. The comments may have shaken investors, as the Dow has already fallen 6% this year, and investors may have been expecting the Fed to make adjustments according to market behavior.

Top 10 Industrial Disributor Stocks To Invest In 2015: Pinnacle Entertainment Inc.(PNK)

Pinnacle Entertainment, Inc. owns, develops, and operates casinos, and related hospitality and entertainment facilities in the United States. It operates casinos, such as L'Auberge du Lac in Lake Charles, Louisiana; River City Casino and Lumiere Place in St. Louis, Missouri; Boomtown New Orleans in New Orleans, Louisiana; Belterra Casino Resort in Vevay, Indiana; Boomtown Bossier City in Bossier City, Louisiana; and Boomtown Reno in Reno, Nevada. The company also operates River Downs racetrack in southeast Cincinnati, Ohio. As of May 26, 2011, it operated seven casinos and one racetrack. The company was formerly known as Hollywood Park, Inc. and changed its name to Pinnacle Entertainment, Inc. in February 2000. Pinnacle Entertainment, Inc. was founded in 1935 and is based in Las Vegas, Nevada.

Advisors' Opinion:
  • [By Grace L. Williams]

    First up is Pinnacle Entertainment (PNK). CEO Anthony Michaal Sanfilippo bought 23,000 shares of the Las Vegas-based gaming company for $505,800. InsiderScore notes this is his first purchase in nearly two years and writes, ��fter shares retreated more than 15% from a six-year high and with an activist hedge fund pushing the casino operator to spin off its real estate into a REIT, Sanfilippo stepped up with his first purchase. [He put] a fresh $500,000 into the stock at a price two times his cost basis of previous buys.��/p>

  • [By Dan Radovsky]

    Pinnacle Entertainment (NYSE: PNK  ) has reached an agreement in principle with the Bureau of Competition of the Federal Trade Commission that would allow the company to complete its proposed acquisition of Ameristar Casinos (NASDAQ: ASCA  ) , Pinnacle announced today.

  • [By Travis Hoium]

    What: Shares of Ameristar Casinos (NASDAQ: ASCA  ) and Pinnacle Entertainment (NYSE: PNK  ) fell as much as 11% today after the government brought into question the merger of the two companies.

Top 10 Industrial Disributor Stocks To Invest In 2015: Pain Therapeutics Inc (PTIE)

Pain Therapeutics, Inc., incorporated in May 1998, is a biopharmaceutical company that develops drugs. The Company has four drug candidates in clinical programs, including REMOXY, abuse-resistant hydromorphone, abuse-resistant hydrocodone and a radio-labeled monoclonal antibody to treat metastatic melanoma. It is also working on a new treatment for patients with hemophilia. The Company�� lead drug candidate is REMOXY, which is a painkiller. It has collaboration agreement with King Pharmaceuticals, Inc. (King) develops and commercializes REMOXY and other opioid painkillers. The Company and King jointly managed a Phase III clinical program and New Drug Application (NDA) submission for REMOXY. It is also developing a pipeline of drug candidates in the area of oncology and hematology. It owns all commercial rights to its pipeline of drug candidates in oncology and hematology. As of December 31, 2010, the Company leased approximately 30,700 square feet of space in San Mateo, California and all of its operations are located in San Mateo.

REMOXY

REMOXY is a controlled-release oral capsule form of oxycodone in a highly viscous liquid formulation matrix that includes excipients. It is formulated to help address issues of abuse and misuse of time-release oxycodone tablets. REMOXY�� capsule dosage form provides therapeutic drug levels of oxycodone on a twice-daily dosing schedule, while resisting the rapid increases in plasma levels of oxycodone associated with common methods of abuse and misuse. Its formulation also resists delivery by unapproved routes of administration, such as injection, snorting or inhalation.

Metastatic Melanoma

The Company is developing a drug candidate called PTI-188 to treat metastatic melanoma, a form of skin cancer. PTI-188 is a monoclonal antibody linked to a radioisotope, intended to deliver doses of radiation lethal to melanoma tumors without harming normal tissue. In March 2010, the Company announced data from two open-label! , dose-escalating Phase I studies conducted in Israel to assess the safety, pharmacokinetics, dosimetry and anti-tumor activity of PTI-188. During the year ended December 31, 2010, the second study was completed. The technology used in this program was developed at the Albert Einstein College of Medicine (AECOM). It had licensed worldwide commercial rights to this technology from AECOM.

Hemophilia

The Company has a gene transfer program, initially developed at Stanford University, focused at correcting a genetic disorder in which patients are unable to stop bleeding. During 2010, it conducted a variety of pre-clinical studies with this technology. The Company has licensed worldwide commercial rights to the technology used in this program from Poetic Genetics, LLC (Poetic).

Other product candidates

The Company�� alliance with King includes development of three other abuse-resistant opioid product candidates: hydromorphone, hydrocodone and oxymorphone. Its abuse-resistant formulations of hydromorphone and hydrocodone have completed Phase I clinical trials. In January 2011, the Company announced that the Food and Drug Administration (FDA) had accepted its investigational IND, for abuse-resistant oxymorphone.

The Company competes with Roxane Laboratories, Purdue Pharma, King Pharmaceuticals, Inc., Abbott Laboratories, Cephalon, Endo Pharmaceuticals, Teva Pharmaceuticals, Elkins-Sinn, Watson Laboratories, Ortho-McNeil Pharmaceutical and Forest Pharmaceuticals.

Advisors' Opinion:
  • [By Jessica Alling]

    Elsewhere, Pfizer is evaluating its continued partnership on an experimental oxycodone capsule, Remoxy. The drug is an extended-release formula that is targeted at reducing abuse of the painkiller. After years of setbacks and postponements for FDA approval, Pfizer is weighing its options. Its partners for the drug, Pain Therapeutics (NASDAQ: PTIE  ) and Durect, have both fallen heavily due to the news, with Pain Therapeutics falling more than 50% -- its largest decline ever.

Top 10 Paper Stocks To Watch Right Now: NXP Semiconductors N.V.(NXPI)

NXP Semiconductors N.V., through its subsidiary, NXP B.V., provides mixed signal solutions and standard products worldwide. The company provides amplifiers, audio/radio products, bipolar transistors, data converters, diodes, identification and security products, interface and connectivity products, logic devices, media processors, microcontrollers, MOSFETs, power management integrated circuits (IC), radio frequency devices, sensors, thyristors, television and set-top-box front ends, and logic driver and controller ICs, as well as ESD, EMI, and signal conditioning products. Its products are used in automotive, identification, wireless infrastructure, lighting, mobile, consumer, computing, and industrial applications. NXP Semiconductors N.V. markets its products directly and through distribution to various original equipment manufacturers, original design manufacturers, contract manufacturers, and distributors. The company was formerly known as KASLION Acquisition B.V and ch anged its name to NXP Semiconductors NV in May 2010. NXP Semiconductors N.V. was founded in 2006 and is headquartered in Eindhoven, the Netherlands.

Advisors' Opinion:
  • [By MONEYMORNING.COM]

    And here you'll find Strategic Tech Investor favorites like fabless chip firm NXP Semiconductors NV (Nasdaq: NXPI) and Russian Internet giant Yandex NV (Nasdaq: YNDX).

  • [By Andy Obermueller]

    Instead, the likely winner is a company most people have never heard of -- NXP Semiconductors (Nasdaq: NXPI). It makes the special chips that go in the phone that "talk" to cash registers. The technology is known as near-field communications (NFC), and NXP is the leader, with critical existing supplier relationships with all the major phone manufacturers, including Apple.

  • [By MONEYMORNING]

    In other words, Allegion's offerings range from low-tech - steel doors and conventional locks - to high tech: automated-access and security systems, video monitoring, and systems integration. Its 23 business brands include:

    Interflex Datensysteme GmbH & Co. KG, which offers such workforce-management systems as time accounting and automated scheduling, as well as security systems that include ID and access-card production, closed-circuit (CCTV) video surveillance, and biometrics. CISA, a security pioneer that patented the first electrically controlled lock - back in 1926. It is also the first brand in the world to develop smart-card locks, which are used as electronic keys to safely and efficiently manage gates and entrances. CISA today develops and markets cylinders and locks for any kind of door, including electronic locks, panic bars, door closers, safes, and padlocks. aptiQ Smart Technology, which uses an "open-architecture" to design readers, credentials, and smartphone-based security applications. The aptiQ portfolio includes easy-to-use readers that can accommodate most magnetic-stripe cards. This product line also allows for the creation and use of proximity cards, aptiQ "smartcards," and the latest in so-called "near-field communications" (NFC) technology - the know-how behind our May 2012 recommendation of NXP Semiconductors NV (Nasdaq: NXPI), a stock that has more than doubled. (Coincidentally, NXP is a 2006 spinoff from Koninklijke Philips Electronics NV (NYSE ADR: PHG) - which underscores, again, the profit potential of "spin-off investing.") Bocom Systems, which specializes in video monitoring solutions for city and highway traffic, as well as for airports, government buildings, and general surveillance. That business unit designs, engineers, and installs both security alarm systems and more-complex closed-circuit-based security networks. And Schlage, a 90-year-old company that's one of the top nam

Top 10 Industrial Disributor Stocks To Invest In 2015: Vanguard FTSE All World ex US Index Fund Investor Shares (VEU)

Vanguard FTSE All-World ex-US ETF (the Fund) is an exchange-traded class of shares of Vanguard FTSE All-World ex-US Index Fund. The Fund seeks to track the performance of an index that measures the investment return of stocks of companies located in developed and emerging markets worldwide. The Fund employs a passive management or indexing investment approach designed to track the performance of the FTSE All-World ex US Index (the Index), a free-float-adjusted, market capitalization-weighted index designed to measure equity market performance of international markets.

The Index includes approximately 2,200 stocks of companies located in 47 countries, including both developed and emerging markets. The Fund typically holds 1,200 to 1,300 stocks in the Index (covering nearly 95% of the Index�� total market capitalization) and a representative sample of the remaining stocks. The Fund holds a range of securities that, in the aggregate, approximate the full Index in terms of key characteristics. These key characteristics include industry weightings and market capitalization, as well as certain financial measures, such as price/earnings ratio and dividend yield. The Fund�� investment advisor is The Vanguard Group, Inc.

Advisors' Opinion:
  • [By Philip Springer, President, Retirement Wealth Management, Inc.]

    Our favorite is Vanguard FTSE All-World ex-US (VEU). This all-in-one ETF combines broad diversification, a high yield (4.7%) and a rock-bottom expense ratio (0.15%).

Top 10 Industrial Disributor Stocks To Invest In 2015: Healthcare Services Group Inc. (HCSG)

Healthcare Services Group, Inc., through its subsidiaries, provides housekeeping, laundry, linen, facility maintenance, and food services to nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. It operates in two segments, Housekeeping, Laundry, Linen, and Other services (Housekeeping); and Dietary Department Services (Dietary). The Housekeeping segment offers cleaning, disinfecting, and sanitizing of patient rooms, and areas of client?s facility, as well as laundering and processing of the personal clothing belonging to the facility?s patients. It also engages in laundering and processing bed linens, uniforms, and other assorted linen items utilized by client?s facility, as well as distributes laundry installations. In addition, this segment provides maintenance services that consist of repair and maintenance of laundry equipment, plumbing, and electrical systems, as well as carpentry and painting services. The Dietary segment i nvolves in providing dietician consulting professional services, developing a menu that meets the patient?s dietary needs, and purchasing and preparing the food for delivery to the patients, as well as participates in monitoring the residents? on-going nutritional status through providing dietician consulting professional services. As of December 31, 2009, the company provided services to approximately 2,300 facilities in 47 states. Healthcare Services Group was founded in 1976 and is based in Bensalem, Pennsylvania.

Advisors' Opinion:
  • [By Seth Jayson]

    There's no foolproof way to know the future for Healthcare Services Group (Nasdaq: HCSG  ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result.

Top 10 Industrial Disributor Stocks To Invest In 2015: Lakeland Industries Inc (LAKE)

Lakeland Industries, Inc. (Lakeland), incorporated on April 30, 1986, manufactures and sells a line of safety garments and accessories for the industrial protective clothing markets. Lakeland�� product categories include limited use/disposable protective clothing, chemical protective suits, fire fighting and heat protective apparel, fire fighting and heat protective apparel, reusable woven garments, high visibility clothing and glove and sleeves. The Company�� industrial customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, mortuaries and high technology electronics manufacturers, as well as scientific and medical laboratories. In addition, Lakeland supplies federal, state and local governmental agencies and departments, such as fire and law enforcement, airport crash rescue units, the Department of Defense, the Department of Homeland Security and the Centers for Disease Control.

Limited Use/Disposable Protective Clothing

Lakeland manufactures a line of limited use/disposable protective garments, including coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps and smocks. Limited use garments can also be coated or laminated to splash protection against harmful inorganic acids, bases and other hazardous liquid and dry chemicals. Limited use garments are made from several nonwoven fabrics, which are made of spunlaced polyester, polypropylene, laminates, micropourous films and derivatives. Lakeland incorporates many seaming, heat sealing and taping techniques depending on the level of protection needed in the end uses application.

The users of these garments include integrated oil/petrochemical refineries, chemical plants and related installations, automotive manufacturers, pharmaceutical companies, construction companies, coal, gas and oil power generation utilities and telephone utility companies, laboratories, mortuarie! s and governmental entities. The Company warehouses and sells its limited use/disposable garments primarily at its Decatur, Alabama and China manufacturing facilities and secondarily from warehouses in Hull, United Kingdom; Sao Paulo, Brazil; Toronto, Canada; Buenos Aires, Argentina; Santiago, Chile; Moscow, Russia; Ust-Kamenogorsk, Kazakhstan; Las Vegas, Nevada, and Sinking Spring, Pennsylvania.

High-End Chemical Protective Suits

Lakeland manufactures and sells protective chemical suits and protective apparels from its CRFR, ChemMax 3, 4, Interceptor and other fabrics. These suits are worn by individuals on hazardous material teams and within general industry to provide protection from concentrated and lethal chemical and biological toxins, such as toxic wastes at super fund sites, toxic chemical spills or biological discharges, chemical or biological warfare weapons and chemicals and petro-chemicals present during the cleaning of refineries and nuclear facilities.

Lakeland has also introduced two garments approved by the National Fire Protection Agency (NFPA) for varying levels of protection, which include Interceptor, two multilayer films laminated on either side of durable nonwoven substrate, and ChemMax 4 is a multilayer barrier film laminated to a durable nonwoven substrate. Lakeland manufactures chemical protective clothing at its facilities in Decatur, Alabama, Mexico and China. Using fabrics, such as ChemMax 1, ChemMax 2, ChemMax 3, ChemMax 4 and Interceptor, Lakeland designs, cut, glue and /or sews the materials to meet customer purchase orders.

Fire Fighting and Heat Protective Apparel

The Company manufactures a line of products to protect individuals who work in heat environments. Lakeland's heat protective aluminized fire suit product lines include kiln entry suit, proximity suits and approach suits. Lakeland manufactures fire fighter protective apparel for domestic and foreign fires departments. Lakeland developed the 32-! inch coat! high back bib style (Battalion) bunker gear.

Gloves and Sleeve Products

The Company manufactures and sell glove and sleeve protective products made from Kevlar, a cut and heats resistant fiber produced by DuPont; Spectra, a cut resistant fiber made by Honeywell and its engineered yarns. Lakeland manufactures these string knit gloves primarily at its Mexican facility.

Reusable Woven Garments

Lakeland manufactures and markets a line of reusable and washable woven garments. The Company's product lines include electrostatic dissipative apparel, clean room apparel, flame resistant Nomex/FR Cotton coveralls/pants/jackets and cotton and polycotton coveralls, lab coats, pants and shirts. Lakeland manufactures and sells woven cloth garments at its facilities in China, Mexico and Decatur, Alabama.

High Visibility Clothing

Lakeland Reflective manufactures and markets a line of reflective apparel. The line includes vests, T-shirts, sweatshirts, jackets, coats, raingear, jumpsuits, hats and gloves. Lakeland's domestic vest production occurs at Sinking Spring, Pennsylvania. Much of the manufacturing at this facility is focused on custom vest requirements. In addition to ANSI Reflective items, Lakeland Hi-Visibility manufactures Nomex and FR cotton garments which have reflective trim as a part of their design criteria. These garments are used in rescue operations, such as those encountered with a vehicular crash.

The Company competes with DuPont, Kimberly Clark, Ansell Edmont and Honeywell.

Advisors' Opinion:
  • [By James E. Brumley]

    Did you miss the initial Ebola rally, led by Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) and Lakeland Industries, Inc. (NASDAQ:LAKE)? Don't sweat it - you're not alone. And if you were thinking about diving into either of those names now, forget about it. Both LAKE and TKMR are overbought, and are guaranteed to be volatile (read "unpredictable") in the future. It's not too late to get in on Ebola-mania, however.

  • [By Ben Levisohn]

    What is Lakeland Industries (LAKE)?

    Lakeland Industries

    I’m glad you asked. Lakeland gets more than 90% of its revenue from the manufacture and sale safety garments, and on Sept. 12, it reminded the world that it makes hazmat suits that can be used to stave off Ebola.

    With the deadly virus having finally made its way to US shores, investors are paying attention again today, sending Lakeland’s shares soaring on high volume.

    Shares of Lakeland have gained 8.6% to $7.55, well above its Sept. 12 closing price of $6.85 (though below its high of $9.40 touched on that day).

    Lakeland joins Tekmira (TKMR) and other biotech stocks as those benefiting from the Ebola scare. Let’s hope it doesn’t last.

Top 10 Industrial Disributor Stocks To Invest In 2015: Continental AG (CON)

Continental AG is a Germany-based holding company and automotive industry supplier. It operates two business groups: Automotive Group and Rubber Group. The Automotive Group is divided into Chassis & Safety division, Powertrain division and Interior division. The Chassis & Safety division focuses on the areas of networked driving safety, brakes, driver assistance, chassis, active and passive safety and sensor technology for the avoidance of accidents and injury. The Powertrain division specializes in the powertrain solutions. The Interior division focuses on information, communication and networking solutions. The Rubber Group is divided into Tire division and ContiTech divisions. The Tire division comprises Passenger and Light Truck Tires, including tires for motorcycles. The ContiTech division develops and manufactures functional parts, components and systems for the automotive industry. In February 2014, it acquired Veyance Technologies Inc. Advisors' Opinion:
  • [By Jonathan Morgan]

    Volkswagen, Europe�� biggest automaker, gained 3.7 percent to 168.40 euros. Daimler AG, the third-biggest luxury-vehicle maker, rose 3.9 percent to 49 euros, its highest price since August 2011. Continental AG (CON), Europe�� second-largest auto-parts maker, added 3 percent to 100.30 euros. A measure of carmakers posted the best performance of the 19 industry groups on the Stoxx Europe 600 Index.

  • [By Ruth David]

    Schaeffler AG, the largest investor in Hanover, Germany-based Continental AG (CON), raised 950 million euros on Sept. 17 by selling a 4 percent stake in Europe�� second-largest car-parts maker to reduce debt. Telegraaf Media Groep NV, the publisher of the largest Dutch newspaper, exited its holding in German broadcaster ProSiebenSat.1 Media AG on Sept. 6, making proceeds of about 391 million euros.

Top 10 Industrial Disributor Stocks To Invest In 2015: Novatel Wireless Inc.(NVTL)

Novatel Wireless, Inc. provides wireless broadband access solutions for the mobile communications market worldwide. It operates in two segments, Mobile Computing Products and machine-to-machine (M2M) Products and Solutions. The Mobile Computing Products segment offers MiFi Intelligent Mobile Hotspots, which provide connectivity option for Wi-Fi-enabled devices, such as the iPad, Kindle, tablets, PCs, MP3 players, and gaming devices; USB and PC-Card modems for wireless access; and embedded modules for use in laptop PCs, netbooks, tablets, and other electronic products to provide wireless broadband access. This segment also offers MobiLink mobile communications software suite, an object-oriented application that enables access to connectivity features, such as SMS, multimedia messaging, and virtual private networking, as well as provides video telephony and wireless local area networks management capabilities; and MiFi DLNA Server, which operates on MiFi hotspots and enables user to access and play movies, music, and photos. It serves wireless operators, laptop PC and other original equipment manufacturers, distributors, and various companies in other vertical markets. The M2M Products and Solutions segment provides asset-management solutions utilizing wireless technology and M2M communications devices. It offers Spider MT, SA, and AT integrated solutions and accessories for monitoring and managing mobile and fixed assets, vehicle tracking and telemetric, and workforce tracking and management; Enabler III and HS embedded solutions for various products or equipment to communicate with other computers; and N4A software and design services, including software and design services primarily for asset management solutions. This segment serves transportation companies, industrial companies, manufacturers of medical devices and geographical-location aware devices, and providers of security systems. The company was founded in 1996 and is headquartered i n San Diego, California.

Advisors' Opinion:
  • [By Roberto Pedone]

    Novatel Wireless (NVTL), provides wireless broadband access solutions for the mobile communications market worldwide. This stock closed up 4.1% to $2.01 in Thursday's trading session.

    Thursday's Range: $1.90-$2.02

    52-Week Range: $1.51-$3.55

    Thursday's Volume: 279,000

    Three-Month Average Volume: 147,319

    From a technical perspective, NVTL ripped higher here right above its 50-day moving average of $1.88 with above-average volume. This strong spike to the upside on Thursday is quickly pushing shares of NVTL within range of triggering a near-term breakout trade. That trade will hit if NVTL manages to take out some near-term overhead resistance levels at $2.10 to $2.11 with high volume.

    Traders should now look for long-biased trades in NVTL as long as it's trending above its 50-day at $1.88 or above more near-term support at $1.74 and then once it sustains a move or close above those breakout levels with volume that hits near or above 147,319 shares. If that breakout triggers soon, then NVTL will set up to re-test or possibly take out its next major overhead resistance levels at $2.18 to $2.30. Any high-volume move above those levels will then give NVTL a chance to re-fill some of its previous gap-down-day zone from March that started at $2.85.

  • [By Chris Neiger]

    Today, Sprint (NYSE: S  ) , in�partnership with Novatel Wireless (NASDAQ: NVTL  ) , announced that it will bring the MiFi 500 LTE tri-band wireless hotspot device to Sprint's network on July 19 -- the first tri-band device for the company.

Top 10 Industrial Disributor Stocks To Invest In 2015: Lattice Inc (LTTC)

Lattice Inc., incorporated on October 31, 1994, develops and delivers secure telecommunication solutions. The Company provides products and services, such as Nexus Call Control system, wholesale services, direct services, government services, Aquifer software, SensorView software, and The OneVoice system. The Company derives its revenues from three primary resources, such as providing telecommunications services to correctional facilities and service providers who provide telecommunication services within the industry, selling or licensing the Company's technology, and providing engineering services to other technology companies and government agencies. The Company continues to wholesale call control technology and services to service providers offering communication services to inmates of correctional institutions. In September 2013, Lattice Incorporated established Lattice Communications Inc. in Canada. In November 2013, the Company purchased InnoVisit's video conferencing technology.

Nexus Call Control System (Nexus)

The Company�� Nexus Call Control system is built on the Company's BubbleLink software architecture. BubbleLink is a transaction processing platform that is used to develop and enhance a variety of customizable communications applications. This open source platform is a combination of integrated computer telephony hardware and software. The Nexus Call Control system is capable of handling thousands of call transactions per hour and provides telecom service providers with tools to manage telephone calls. The Nexus Call Control system can manage small to facilities without sacrificing features or performance. Nexus provides call control and management tools targeted at investigation and law enforcement in the inmate telephone control industry.

Nexus includes live monitoring, debit, video visitation, kiosk integration, and recording features. The Nexus system can be structured to use pre-paid collect and pre-paid debit cards that support specialized tarif! fs and call timing. With pre-paid services, Nexus provides complete control and security. Nexus call control systems are supported by an integrated array of administrative and investigative programs that provide a management solution suite. All programs interact in real-time with Nexus calls and databases via an Ethernet local area network (LAN) or a wide area network (WAN).

Wholesale Services

The Company provides transaction based services to other service providers based on the feature set of the Nexus platform. Service providers utilize the Company's services to provide telecommunication services to facilities that require a secure call management solution. The features the Company offers vary based on the specific needs of the service provider. With the scalability of the Nexus system, the Company is able to provide services across the country without requiring a capital deployment for new facilities.

Direct Services

The Company's Nexus platform allows the Company to provide correctional facilities with a feature rich secure call control service that enables inmates to make phone calls while providing the security and investigative features required in correctional facilities. In addition to telecommunications services the Nexus based system provides capabilities to provide services, such as video visitation, kiosk management, e-mail, and other inmate services not readily available through less advanced systems. With the Nexus based platform, because it is centrally located, the Company is able to provide a suite of features to smaller facilities, enabling the Company to provide services traditionally unavailable to this section of the market.

Government Services

The Company�� government services division provides engineering services coupled with technology solutions to agencies of the federal government. The Company has developed data management applications, Internet server technology, and information systems within! federal ! agencies.. The Company's technology and services helps the Company's customers reduce development time for projects, manage the deployment of applications across the Internet to desktops around the world and implement military grade security on all systems where the applications are deployed. The Company has designed, developed and implemented advanced business management applications, integration technologies and enterprise geospatial systems.

The Company supports several operational systems in all of these categories for organizations and defense commands using Web-based technologies and the consolidation of custom and commercial off-the-shelf software to unite dissimilar applications into integrated systems. In addition, the Company provides network engineering, architectural guidance, database management, programming, and functional area analysis to its department of defense clients. The government services division derives approximately 90% of its revenues from the department of defense. The Company's contracts with the federal government consist of three contract types: time and materials, fixed price, and cost plus. In addition, the Company has a mix of prime contracts, where the contract is awarded to the Company, and subcontracts where the Company is a sub on another organization's prime contract. The Company has approximately 90% of its revenues being generated from prime contracts.

Aquifer Software

The Company develops and markets the Aquifer application services platforms, a software product embedded in the applications developed for its customers. Aquifer is an out-of-the-box application framework for secure, Web-enabled, multi-platform applications. It implements application and data security that exceeds military and commercial standards. Built on Web services, Aquifer provides developers with a simplified, clear path to implement applications in a service oriented architecture (SOA). Using Aquifer, developers accelerate the creation, conversion, d! eployment,! and maintenance of next generation, Internet-ready, multi-tiered business applications.

SensorView Software (SensorView)

The Company�� SensorView is a command, control, and monitoring system that provides a secure plug and play (SPnP) backbone for the integration of numerous CBRNE, weather, navigation, video, motion, and other sensor types using a variety of standard wired and wireless interfaces. It can be used with both fixed and mobile units to provide real time monitoring and protection. SensorView software is microsoft windows and Internet browser based for ease of use with a customizable interface that is easy to learn and modify to the specific display needs of the user. SensorView can be used with or without encryption and can be exported for use by Allied Coalition partner nations.

The OneVoice System (OneVoice)

The Company�� OneVoice system, also known as the JWARN Component Interface Device (JCID) on a Chip, or JoaC, is a universal network card that allows non-standard CBRNE or other sensor types to communicate with JWARN and other standardized command and control sensor platforms. OneVoice acts as a protocol translator for legacy sensors, allowing connectivity through both the JWARN JCID interface (JJI) and the common chemical, biological, radiological, nuclear, and explosive (CBRN) sensor interface (CCSI). The system can be integrated directly with a sensor, or hung externally as a dongle to provide the needed connectivity. The OneVoice network card also contains onboard RAM and Flash memory, as well as an integrated global positioning system (GPS), providing the ability to perform data fusion and computation at the node itself, which delivers added power to mesh network sensor configurations.

Advisors' Opinion:
  • [By Peter Graham]

    Small cap stocks Timios National Corp (OTCMKTS: HOMS) and Lattice Inc (OTCMKTS: LTTC) surged 54.29% and 20.83%, respectively, while Unique Pizza & Subs Corp (OTCMKTS: UPZS) sank 27.27% last Friday. But today is a new trading week with the last two trading days for the year. So what will these three small caps do today, tomorrow and after New Years�� Here is a closer look:

Top 10 Industrial Disributor Stocks To Invest In 2015: Ryland Group Inc (RYL)

The Ryland Group, Inc., incorporated on March 28, 1967, is a homebuilders and a mortgage-finance company. In addition, Ryland Mortgage Company and its subsidiaries, and RMC Mortgage Corporation (collectively referred to as RMC) provide mortgage financing and related services. All of the Company's business is conducted and located in the United States. The Company's operations span aspects of the home buying process from design, construction and sale to mortgage origination, title insurance, escrow and insurance services. During the year ended December 31, 2012, the homebuilding operations were consisted of approximately 97% of consolidated revenues. The homebuilding segments generate their revenues from sales of completed homes, with sales of land and lots. The Company builds homes for entry-level buyers, as well as for first- and second-time move-up buyers. In July 2012, the Company acquired Charlotte and Raleigh operations and assets of Timberstone Homes. In December 2012, the Company acquired Phoenix operations and assets of Trend Homes. In June 2013, Ryland Group Inc acquired LionsGate Homes Corp. Effective July 19, 2013, Ryland Group Inc acquired Cornell Homes, a media-based construction company.

Homebuilding

The Company's homes are built on-site and marketed in four geographic regions or segments: North, Southeast, Texas and West. Its North segment includes Baltimore, Chicago, Indianapolis, Minneapolis, Northern Virginia and Washington, D.C. Its Southeast include Atlanta, Charleston, Charlotte, Orlando and Tampa. Texas includes Austin, Houston and San Antonio. West includes Denver, Las Vegas and Southern California. During 2012, within each of those segments, the Company operated in the metropolitan areas of North, Southeast, Texas and West. Each of its homebuilding divisions across the country consists of a division president; a controller; management personnel focused on land entitlement, acquisition and development, sales, construction, customer service and purchasin! g, and accounting and administrative personnel. The Company markets attached and detached single-family homes. In the Company's single-family detached home communities, it offers at least four different floor plans. The Company's attached home communities offer different floor plans with two, three or four bedrooms. The Company relies on its own architectural staff and also engages unaffiliated architectural firms to develop new designs. Homebuyers are able to customize certain features of their homes by selecting from options and upgrades displayed in the Company's model homes and design centers. In all of the Company's communities, a range of options is available to homebuyers for additional charges. The number and complexity of options increase with the size and base selling price of the home. During 2012, custom options contributed 16.9% of homebuilding revenues.

The Company's financial services segment provides mortgage-related products and services, as well as title, escrow and insurance services, to its homebuyers. The Company's financial services segment includes RMC, RH Insurance Company, Inc. (RHIC), LPS Holdings Corporation and its subsidiaries (LPS), and Columbia National Risk Retention Group, Inc. (CNRRG). By aligning its operations with the Company's homebuilding segments, the financial services segment leverages this relationship to offer its lending services to homebuyers.

During 2012, RMC's mortgage origination operations consisted of the Company's homebuilder loans, which were originated in connection with sales of the Company's homes. During 2012, mortgage operations originated 3,039 loans, which used for purchasing homes built by the Company and for purchasing homes built by others, purchasing existing homes or refinancing existing mortgage loans. RMC arranges various types of mortgage financing, including conventional, Federal Housing Administration (FHA) and Veterans Administration (VA) mortgages, with various fixed- and adjustable-rate features. The Compa! ny sells ! the loans it originates, along with the related servicing rights, to others. Cornerstone Title Company, doing business as Ryland Title Company, is a 100 % subsidiary of RMC, provides escrow and title services and acts as a title insurance agent primarily for the Company's homebuyers. As of December 31, 2012, it provided title services in Arizona, Colorado, Florida, Illinois, Indiana, Maryland, Minnesota, Nevada, Texas and Virginia. Ryland Insurance Services (RIS), a 100 % owned subsidiary of RMC, provides insurance services to the Company's homebuyers. As of December 31, 2012, RIS was licensed to operate in all of the states in which the Company's homebuilding segments operate. During 2012, it provided insurance services to 41.5 % of the Company's homebuyers. CNRRG, a 100 %-owned subsidiary of the Company and some of its affiliates, offer insurance, specifically structural warranty coverage, to protect homeowners against liability risks arising in connection with the homebuilding business of the Company and its affiliates.

Advisors' Opinion:
  • [By Laura Brodbeck]

    Wednesday

    Earnings Expected From: Marriott International (NYSE: MAR), MetLife, Inc. (NYSE: MET), Facebook, Inc. (NASDAQ: FB), Garmin Ltd (NASDAQ: GRMN), Ryland Group, Inc. (NYSE: RYL) Economic Releases Expected: British consumer confidence, New Zealand Interest rate decision, US FOMC meeting announcement, German CPI, US GPD, US core CPI, US nonfarm employment change

    Thursday

  • [By Ben Levisohn]

    Homebuilding stocks have plunged on the news. The Ryland Group (RYL) has fallen 4.6% to $35.15, Toll Brothers (TOL) has dropped 3.1% to $31.45, KB Home (KBH) has declined 3.1% to $16.67 and DR Horton (DHI) is off 2.8% at $18.74. Pulte Group (PHM) has dropped 2.7% at $15.80.

Sunday, March 29, 2015

Top Chemical Companies To Watch For 2015

Top Chemical Companies To Watch For 2015: Givaudan SA (GIVN)

Givaudan SA is a Switzerland-based holding company engaged in the fragrance and flavor industry. The Company has two business divisions: Fragrances and Flavors. The Fragrances business segment comprises the manufacture and sale of fragrances into three global business units: Fine Fragrances, comprising signature fragrances and line extensions, Consumer Products, comprising fabric and personal care, hair and skin care, household and air care, as well as oral care, and Fragrance Ingredients. The Flavors business division comprises the manufacture and sale of flavors into four business units: Beverages, comprising flavors for soft drinks, fruit juices and instant beverages; Dairy, comprising ice cream, yoghurt, desserts and yellow fats; Savory, covering soups and sauces, among others; and Confectionery. The Company is also engaged in research and development activities, which comprises the development of a palette of perfumery raw materials, both synthetic and natural. Advisors' Opinion:
  • [By Celeste Perri]

    Nestle SA (NESN) is selling Givaudan (GIVN) SA shares worth $1.27 billion at yesterdays closing price to institutional investors, winding down its stake in the worlds largest flavorings maker.

  • [By Inyoung Hwang]

    Berkeley Group Holdings Plc (BKG) surged 8.3 percent after saying first-half profit rose 22 percent. London Stock Exchange Group Plc (LSE) climbed 2.4 percent after Bank of America Corp.s Merrill Lynch unit recommended buying the stock. Givaudan SA (GIVN) lost 1.3 percent after Nestle SA said it will sell $1.27 billion of shares in the worlds largest flavorings maker.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series! . Today, we're checking in on Given Imaging (Nasdaq: GIVN  ) , whose recent revenue and earnings are plotted below.

  • source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-chemical-companies-to-watch-for-2015.html

Friday, March 27, 2015

Top Medical Companies To Buy For 2014

By Shayla Mars

No one wants to think about the aging of his or her parents, let alone plan for their death. Unfortunately, aging is a part of life, and in order to truly support your parents, it�� best to start asking questions now.

According to the National Funeral Directors Association, the average funeral in 2009 (without the glamor of flowers, and etc.) cost $6,560. Fidelity Investments recently estimated that a retiring couple would need about $240,000 to cover medical expenses (not taking into account employee-provided health benefits).

Of course, the most time consuming thoughts are not about the cost themselves, but rather how to afford the cost. As you parents get older here are 7 questions you need to ask.

1. Do you have a will?

Most of us have heard horror stories about families arguing over property left behind from deceased loved ones. Wills are extremely hard to discuss with an elderly parent because it can present the reality of dying.

Best Income Companies To Own In Right Now: Biodel Inc (BIOD)

Biodel Inc. (Biodel), incorporated on December 3, 2003, is a development-stage speciality biopharmaceutical company focused on the development and commercialization of treatments for diabetes. The Company develops its product candidates by applying its formulation technologies to existing drugs. Its advanced program involves developing formulations of injectable recombinant human insulin (RHI). In addition to its ultra-rapid-acting insulin formulations, the Company has developed prototype formulations of a liquid glucagon, a basal insulin and a glucose responsive insulin, in each case for use by patients with diabetes. RHI-based formulation known as Linjeta was the subject of a New Drug Application (NDA).

The Company has two pivotal Phase III clinical trials with its preferred commercial formulation of Linjeta prior to re-submitting the NDA. In August 2011, it completed patient visits and analyzed top-line data from the first Phase 1 clinical trial of two RHI-based formulations. The trial was a single-center, randomized, double-blind, three-period crossover trial in 18 subjects with Type 1 diabetes. The purpose of the trial was to evaluate the pharmacokinetic and pharmacodynamic characteristics and injection site toleration of BIOD-105 and BIOD-107, as compared to the insulin analog marketed as Humalog. The Company conducted Phase I, Phase II and Phase III clinical trials comparing the performance of its Linjeta formulation of RHI to either Humulin, which is a branded formulation of RHI or Humalog. Its pivotal Phase III clinical trials were open-label, parallel group, randomized trials conducted at centers in the United States, Germany and India.

The Company competes with Eli Lilly, Novo Nordisk, Sanofi-Aventis, Halozyme Therapeutics, Inc. and MannKind Corporation.

Advisors' Opinion:
  • [By Monica Gerson]

    Biodel (NASDAQ: BIOD) is expected to post a Q1 loss at $0.24 per share.

    First Majestic Silver (NYSE: AG) is estimated to post its Q1 earnings at $0.10 per share on revenue of $63.35 million.

  • [By Roberto Pedone]

    One under-$10 specialty biopharmaceutical player that's starting to trend within range of triggering a big breakout trade is Biodel (BIOD), which is focused on the development and commercialization of innovative treatments for diabetes. This stock has been hit hard by the bears over the last three months, with shares down by 24%.

    If you take a look at the chart for Biodel, you'll notice that this stock is ripping higher here right off its 50-day moving average of $2.32 a share with strong upside volume. Volume on Thursday has so far registered over 750,000 shares, which is well above its three-month average action of 445,084 shares. This move is quickly pushing shares of BIOD within range of triggering a big breakout trade.

    Traders should now look for long-biased trades in BIOD if it manages to break out above some near-term overhead resistance levels at $2.52 to $2.60 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 445,084 shares. If that breakout triggers soon, then BIOD will set up to re-test or possibly take out its next major overhead resistance levels $3 to its 200-day moving average of $3.39 a share. Any high-volume move above $3.39 will then give BIOD a chance to tag $4 a share.

    Traders can look to buy BIOD off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $2.10 a share. One can also buy BIOD off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top Medical Companies To Buy For 2014: Tandem Diabetes Care Inc (TNDM)

Tandem Diabetes Care, Inc., incorporated on July 1, 2008, is a medical device company with an approach to the design, development and commercialization of products for people with insulin-dependent diabetes. The Company designed and commercialized its flagship product, the t:slim Insulin Delivery System, or t:slim, based on its technology platform and consumer-focused approach. Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump�� cartridge rather than relying on a syringe and plunger mechanism. The Company also applies the science of human factors to its design and development process, which seeks to optimize its devices to the intended users, allowing users to successfully operate the devices in their intended environment.

The Company developed t:slim to offer the specific features that people with insulin-dependent diabetes seek in a next-generation insulin pump. The Company designed it to have the look and feel of a modern consumer electronic device, such as a smartphone. It is the insulin pump to feature a high resolution, color touchscreen. It is also the slimmest and smallest durable insulin pump on the market, and can easily and discreetly fit into a pocket, while still carrying a cartridge with 300 units of insulin.

The Company designed its flagship product, t:slim, to have the look and feel of a modern consumer electronic device, such as a smartphone. t:slim is the slimmest and smallest durable insulin pump on the market. With its narrow profile, which is similar to many smartphones, t:slim can easily and discreetly fit into a pocket. Its technology platform allows for the use of a vivid touchscreen and easy-to-navigate software architecture, which provide users simple access to the key functions of t:slim directly from the Home Screen. Insulin pump users can quickly learn how to efficiently navigate t:slim�� software, thereby enabling healthcare providers to spend! less time teaching a person how to use the pump and more time improving management of their diabetes. Its software also features numerous shortcuts, including a simple way to return to the Home Screen and view critical information for therapy management. Its technology is specifically designed to help prevent the unintentional delivery of insulin and reduce fear associated with using a pump.

Advisors' Opinion:
  • [By Paul Ausick]

    Insulin pump maker Tandem Diabetes Care Inc. (NASDAQ: TNDM) sold 8 million shares on Thursday at an IPO price of $15. The stock began trading at around $19 before closing about flat to the opening bid and then shooting up more than 13% on Friday to close at $21.84.

Top Medical Companies To Buy For 2014: Waters Corp (WAT)

Waters Corporation (Waters), incorporated on December 6, 1991, is an analytical instrument manufacturer that primarily designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans. These systems are complementary products that are frequently employed together (LC-MS) and sold as integrated instrument systems using a common software platform and are used along with other analytical instruments. Through its TA Division (TA), the Company primarily designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments. The Company is also a developer and supplier of software-based products that interface with the Company's instruments and are typically purchased by customers as part of the instrument system. The Company's products are used by pharmaceutical, life science, biochemical, industrial, nutritional safety, environmental, academic and governmental customers working in research and development, quality assurance and other laboratory applications. The Company operates in two segments: Waters Division and TA Division.

In January 2012, the Company acquired Baehr Thermoanalyse GmbH. In July 2012, the Company acquired Blue Reference, Inc. During the year ended December 31, 2012, the Company introduced the Xevo G2-S Q-TofTM and Xevo G2-S Tof mass spectrometers, bringing StepWave ion technology to its bench-top time-of-flight mass spectrometers.

Waters Division

HPLC is used to identify and analyze the constituent components of a variety of chemicals and other materials. HPLC is used to identify new drugs, develop manufacturing methods and assure the potency and purity of new pharmaceuticals. HPLC is also used in a variety of other applica! tions, such as analyses of foods and beverages for nutritional labeling and compliance with safety regulations, the testing of water and air purity within the environmental testing industry, as well as applications in other industries, such as chemical and consumer products. HPLC is also used by universities, research institutions and governmental agencies, such as the United States Food and Drug Administration (FDA) and the United States Environmental Protection Agency (EPA). The ACQUITY UPLC I-Class provides a solution to a critical need by successfully analyzing compounds that are limited in amount or availability.

Waters manufactures LC instruments that are offered in configurations that allow for varying degrees of automation, from component configured systems for academic research applications to fully automated systems for regulated testing, and that have a variety of detection technologies, from ultra-violet (UV) absorbance to MS, optimized for certain analyses. The Company also manufactures tailored LC systems for the analysis of biologics, as well as an LC detector utilizing evaporative light scattering technology to expand the usage of LC to compounds.

The primary consumable products for LC are chromatography columns. These columns are packed with separation media used in the LC testing process and are replaced at regular intervals. The Company's chemistry consumable products also include environmental and nutritional safety testing products. Environmental laboratories use these products for quality control and proficiency testing and also purchase product support services required to help with their federal and state mandated accreditation requirements or with control over critical pharmaceutical analysis. In addition, the Company provides tests to identify and quantify mycotoxins in various agricultural commodities. These test kits provide reliable, quantitative detection of particular mycotoxins through the choice of flurometer, LC-MS or HPLC.

The Co! mpany off! ers a range of MS instrument systems utilizing various combinations of quadrupole, Tof, ion mobility and magnetic sector designs. These instrument systems are used in drug discovery and development, as well as for environmental, clinical and nutritional safety testing. The spectrometers sold by the Company are designed to utilize an LC system as the sample introduction device.

The Company�� smaller-sized mass spectrometers, such as the single quadrupole detector (SQD) and the tandem quadrupole detector (TQD), referred to as LC detectors and are sold as part of an LC system or as an LC system upgrade. Quadrupole systems, such as the Xevo TQ and Xevo TQ-S instruments, are used for late-stage drug development, including clinical trial testing. Quadrupole time-of-flight (Q-Tof) instruments, such as the Company�� SYNAPT G2-S, are used to analyze the role of proteins in disease processes, an application referred to as proteomics. Its SYNAPT G2 HDMS and SYNAPT G2 MS systems are exact mass MS/MS platforms. The Company�� Xevo TQ-S instrument system is designed for UPLC/MS/MS applications. Its Xevo G2 Q-Tof is exact mass quantitative and qualitative bench-top MS/MS instrument systems. The Company�� SYNAPT G2-S incorporates Waters StepWave ion transfer optics and Triwave ion mobility technologies along with a range of informatics tools.

TA Division

Thermal analysis measures the physical characteristics of materials as a function of temperature. Rheometry instruments complement thermal analyzers in characterizing materials. Rheometry characterizes the flow properties of materials and measures their viscosity, elasticity and deformation under different types of loading or other conditions.

Thermal analysis measures the physical characteristics of materials as a function of temperature. Rheometry instruments complement thermal analyzers in characterizing materials. Rheometry characterizes the flow properties of materials and measures their viscosity, elast! icity and! deformation under different types of loading or conditions. As with systems offered through the Waters Division, a range of instrumental configurations is available with sample handling and information processing automation. In addition, systems and accompanying software packages can be tailored for specific applications. The Company�� Q-Series family of differential scanning calorimeters includes a range of instruments, from analyzers to systems, which can accommodate robotic sample handlers and a range of sample cells and temperature control features for analyzing a range of materials.

The Company competes with Agilent Technologies, Inc., Shimadzu Corporation, Bruker Corporation, Danaher Corporation, Thermo Fisher Scientific Inc, PerkinElmer, Inc., Mettler-Toledo International Inc., NETZSCH-Geraetebau GmbH, Thermo Fisher Scientific Inc., Malvern Instruments Ltd., Anton-Paar, Phenomenex, Inc., Supelco, Inc., Merck and Co., Inc. and General Electric Company.

Advisors' Opinion:
  • [By Teresa Rivas]

    Danaher (DHR) and Waters Corporation (WAT) were mirror images of one another, with the former rising 1.3% at recent check and the latter falling by 1.3%.

  • [By Geoff Gannon] strong>Balchem (BCPC)

    路 Idexx (IDXX)

    路 II-VI (IIVI)

    路 Mesa Laboratories (MLAB)

    路 Masimo (MASI)

    I don�� know most of those companies very well. I probably know Waters the best out of that group.

    Obviously, there are companies outside of Phil Fisher�� area of focus ��manufacturing with technical elements ��that fit many of his principles.

    Among really high profile companies, the three that stand out are:

    1. Amazon (AMZN)

    2. Netflix (NFLX)

    3. Wells Fargo (WFC)

    Of those 3, Amazon stands out the most. Jeff Bezos often seems to be channeling Phil Fisher. And I imagine that if Fisher were ever interested in a retailer it would be a retailer with Amazon�� attitude about technology, customers, growth, and the long-term. More than anything though it�� Amazon�� constant internal push to develop new sales and especially new ways to serve existing customers without being prompted by outside forces that makes me think it�� a company Phil Fisher would be very interested in.

    Fisher liked companies that had a philosophy of growth. Something internal to the organization that caused it to seek ways to grow sales, win new customers, develop new products. Fisher obviously wanted a great organization in an industry with great long-term prospects. But I think a lot of growth investors focus more on the latter issue than Fisher would. I know they don�� focus enough on the first issue. Fisher wanted a great organization first and foremost.

    I�� not sure any of the stocks I��e mentioned in this article are necessarily good buys. The one exception is Wells Fargo. I�� never comfortable calling a bank entirely safe. So I�� less sure about suggesting any financial stock as a good buy than I am about stocks in most industries. But if you look at what Wells Fargo has achieved and what they are likely to achieve over the next ten years or so and then consider the price you are paying f

Top Medical Companies To Buy For 2014: Atrion Corp (ATRI)

Atrion Corporation (Atrion), and its subsidiaries, develop and manufacture products, primarily for medical applications. The Company�� medical products range from fluid delivery devices to ophthalmic and cardiovascular products. During the year ended December 31, 2011, the Company�� fluid delivery products accounted for 38% of the Company�� revenues. These products include valves that promote infection control and needle safety. The Company has developed a variety of luer syringe check valves and one-way valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, catheter and other applications. The Company also makes tubing clamps in a variety of materials and colors that are compatible with various grades of tubing and sterilization processes, and produce specialized intravenous sets for use in numerous applications, including anesthesia and oncology.

The Company�� cardiovascular products accounted for 29% of its revenues during 2011. The Company's principal cardiovascular product is the Myocardial Protection System (MPS2), a technology that delivers essential fluids and medications to the heart during open-heart surgery. The MPS2 integrates key functions relating to the delivery of solutions to the heart, such as varying the rate and ratio of oxygenated blood, crystalloid, potassium and other additives, and controlling temperature, pressure and other variables to allow simpler, more flexible management of this process, indicating improved patient outcomes. The MPS2 is the device used in open-heart surgery that allows for the mixing of drugs into the bloodstream without diluting the blood. The MPS2 employs advanced pump, temperature control and microprocessor technologies and includes a line of disposable products. It also develops and manufactures other cardiovascular products that include cardiac surgery vacuum relief valves; Retract-O-Tape silicone vessel loops for retracting and occluding vessels in minimally inva! sive surgical procedures; inflation devices for balloon catheter dilation, stent deployment and fluid dispensing, and Clean-Cut rotating aortic punch and PerfectCut Aortotomy System, both of which are used in heart bypass surgery to make a precision opening in the heart for attachment of the bypass vessels.

The Company�� ophthalmic products accounted for 17% of its revenues during 2011. The Company is a manufacturer of contact lens disinfection cases. It also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. The Company�� other medical and non-medical products accounted for 16% of its revenues during 2011. These product lines consist of instrumentation and associated disposables used to measure the activated clotting time of blood. In addition, it manufactures and sells a line of products designed for safe needle and scalpel blade containment. It is also the manufacturer of inflation systems and valves used in marine and aviation safety products. The Company manufactures inflation systems and valves for products, such as life vests, life rafts, inflatable boats, survival equipment and other inflatable structures. The Company also produces one-way and two-way pressure relief valves for use on electronics cases, munitions cases, pressure vessels, transportation container cases, escape slides, and many other medical and non-medical applications.

The Company market components to other equipment manufacturers for incorporation in their products and sell finished devices to physicians, hospitals, clinics and other treatment centers. It sells its products through a sales force which consists of direct sales personnel, independent sales representatives and distributors. It offers customer service, training and education, and technical support such as field service, spare parts, maintenance and repair for certain of its products. The Company�� medical products and other components are produced at facilities in ! Florida, ! Alabama and Texas.

Advisors' Opinion:
  • [By Seth Jayson]

    There's no foolproof way to know the future for ATRION (Nasdaq: ATRI  ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result.

Top Medical Companies To Buy For 2014: Celgene Corp (CELG)

Celgene Corporation is a global biopharmaceutical company primarily engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases. The Company is engaged in the research and development, which is designed to bring new therapies to market, and is engaged in research in several scientific areas that may deliver therapies, focusing areas, such as intracellular signaling pathways in cancer and immune cells, immunomodulation in cancer and autoimmune diseases, and therapeutic application of cell therapies. The Company�� primary commercial stage products include REVLIMID, VIDAZA, THALOMID, ABRAXANE and ISTODAX. Additional sources of revenue include a licensing agreement with Novartis, which entitles it to royalties on FOCALIN XR and the entire RITALIN family of drugs, the sale of services through its Cellular Therapeutics subsidiary and other miscellaneous licensing agreements. In March 2012, it acquired Avila Therapeutics.

The Company invests in research and development, and the drug candidates in its pipeline at various stages of preclinical and clinical development. These candidates include pomalidomide and apremilast, its oral anti-cancer and anti-inflammatory agents, PDA-001, its cellular therapy, oral azacitidine, CC-223 and CC-115 for hematological and solid tumor malignancies, CC-122, its anti-cancer pleiotropic pathway modifier, and ACE-011 and ACE-536 biological products for anemia in several clinical settings of unmet need. Celgene product candidates include Pomalidomide (CC-4047), Oral Anti-Inflammatory: Apremilast (CC-10004), CC-11050, Kinase Inhibitors:Tanzisertib (CC-930), Cellular Therapies: PDA-001, Activin Biology: Sotatercept (ACE-011) ACE-536, and Anti-tumor Agents: CC-22, CC-115, CC-122 and Oral Azacitidine. It owns and operates a manufacturing facility in Zofingen, Switzerland. The Company also owns and operates a drug product manufacturing facility in Boudry, Switzerland.

Commercial! Stage Products

REVLIMID (lenalidomide) is an oral immunomodulatory drug marketed in the United States and many international markets, in combination with dexamethasone, for treatment of patients with multiple myeloma who have received at least one prior therapy. It is also marketed in the United States and certain international markets for the treatment of transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. REVLIMID is distributed in the United States through contracted pharmacies under the RevAssist program, which is a risk-management distribution program. Internationally, REVLIMID is distributed under mandatory risk-management distribution programs.

REVLIMID continues to be evaluated in numerous clinical trials worldwide either alone or in combination with one or more other therapies in the treatment of a range of hematological malignancies, including multiple myeloma (MDS) various lymphomas, chronic lymphocytic leukemia (CLL) other cancers and other diseases. VIDAZA (azacitidine for injection) is a pyrimidine nucleoside. VIDAZA is a Category 1 recommended treatment for patients with intermediate-2 and high-risk MDS and is marketed in the United States for the treatment of all subtypes of MDS. In Europe, VIDAZA is marketed for the treatment of intermediate-2 and high-risk MDS, as well as acute myeloid leukemia (AML) with 30% blasts and has been granted orphan drug designation for the treatment of MDS and AML.

THALOMID (thalidomide) is marketed for patients with newly diagnosed multiple myeloma and for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL) an inflammatory complication of leprosy and as maintenance therapy for prevention and suppression of the cutaneous manifestation of ENL recurrence. THALOMID is distributed in the United States under its System f! or Thalid! omide Education and Prescribing Safety (S.T.E.P.S.) program. Internationally, THALOMID is also distributed under mandatory risk-management distribution programs. ABRAXANE (paclitaxel albumin-bound particles for injectable suspension) is a solvent-free chemotherapy treatment option for metastatic breast cancer, which was developed using its nab technology platform. This protein-bound chemotherapy agent combines paclitaxel with albumin. As of December 31, 2011, ABRAXANE was in various stages of investigation for the treatment of expanded applications for metastatic breast; non-small cell lung; malignant melanoma; pancreatic; bladder and ovarian.

ISTODAX (romidepsin) has received orphan drug designation for the treatment of non-Hodgkin's T-cell lymphomas, which includes CTCL and PTCL. The Company has licensed the worldwide rights (excluding Canada) regarding certain chirally pure forms of methylphenidate for FOCALIN and FOCALIN XR to Novartis. It also licensed to Novartis the rights related to long-acting formulations of methylphenidate and dex-methylphenidate products which are used in FOCALIN XR and RITALIN LA.

Preclinical and Clinical-Stage Pipeline

The product candidates in the Company�� pipeline are at various stages of preclinical and clinical development. Pomalidomide is a small molecule that is orally available and modulates the immune system and other biologically important targets. Pomalidomide is being evaluated in a phase III clinical trial for the treatment of myelofibrosis and a phase III clinical trial evaluating pomalidomide as a treatment for patients with relapsed/refractory multiple myeloma is accruing patients.

The Company is developing a product, ORAL ANTI-INFLAMMATORY AGENTS, which is orally available small molecules that target PDE4, an intracellular enzyme that modulates the production of multiple pro-inflammatory and anti-inflammatory mediators, including interleukin-2 (IL-2), IL-10, IL-12, IL-23, INF-gamma, TNF-a, leukotrienes,! and nitr! ic oxide synthase. Its investigational drug, apremilast (CC-10004), is used for the treatment of moderate to severe psoriasis and active psoriatic arthritis and is being evaluated in a phase II trial for rheumatoid arthritis and six phase III multi-center international clinical trials. In addition, it is investigating its oral PDE4 inhibitor, CC-11050, which is an anti-inflammatory compound that treat a variety of chronic inflammatory conditions, such as Cutaneous Lupus Erythematosus (CLE).

The Company�� oral kinase inhibitor platform includes inhibitors of the c-Jun N-terminal kinase (JNK) mTOR kinase, spleen tyrosine kinase (Syk) c-fms tyrosine kinase (c-FMS) and DNA-dependent protein kinase (DNAPK). Its oral Syk, c-FMS and DNAPK kinase inhibitors are being investigated in pre-clinical studies. The Company�� new second generation JNK inhibitor, tanzisertib (CC-930), is being evaluated in a phase II trial for the treatment of idiopathic pulmonary fibrosis and a phase II trial for the treatment of discoid lupus is accruing patients. Amrubicin is a third-generation fully synthetic anthracycline molecule with potent topoisomerase II inhibition.

At Celgene Cellular Therapeutics (CCT), it is researching stem cells derived from the human placenta, as well as from the umbilical cord. CCT is the Company�� research and development division. Stem cell based therapies provide disease-modifying outcomes for serious diseases, which lack adequate therapy. It has developed technology for collecting, processing and storing placental stem cells with broad therapeutic applications in cancer, auto-immune diseases, including Crohn's disease, multiple sclerosis, neurological disorders, including stroke and amyotrophic lateral sclerosis (ALS), graft-versus-host disease, and other immunological / anti-inflammatory, rheumatologic and bone disorders.

The Company has collaborated with Acceleron Pharma, Inc. (Acceleron) to develop sotatercept. Two phase I clinical studies have been co! mpleted. ! An additional phase II clinical study has been initiated and is ongoing related to treatments for end-stage renal anemia and to evaluate effects on red blood cell mass and plasma volume.

The Company competes with Abbott Laboratories, Amgen Inc. (Amgen), AstraZeneca PLC., Biogen Idec Inc., Bristol-Myers Squibb Co., Eisai Co., Ltd., F. Hoffmann-LaRoche Ltd., Johnson and Johnson, Merck and Co., Inc., Novartis AG, Pfizer, Sanofi and Takeda Pharmaceutical Co. Ltd. (Takeda).

Advisors' Opinion:
  • [By Ben Levisohn]

    Shares of Gilead Sciences has dropped 1.3% to $81.52 at 10:33 a.m., while Amgen (AMGN) has fallen 0.3% to $123.78,�Biogen Idec�(BIIB) has gained 0.8% to $331.07 and�Celgene (CELG) has risen 1.1% to $166.59. The�SPDR S&P Biotech ETF�(XBI) has advanced 0.6% to $153.43.

Top Medical Companies To Buy For 2014: Brainstorm Cell Therapuetics Inc (BCLI)

Brainstorm Cell Therapeutics Inc. (Brainstorm), incorporated on November 15, 2006, is a biotechnology company developing adult stem cell therapies for debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS), and Parkinson�� disease (PD). These diseases have limited treatment options and as such represent unmet medical needs. The Company�� NurOwn technology is based on a differentiation protocol, which induces differentiation of the bone marrow-derived mesenchymal stem cells into neuron-supporting cells, MSC-NTF cells, capable of releasing several neurotrophic factors, including Glial-derived neurotrophic factor (GDNF) and Brain-derived neurotrophic factor (BDNF), Vascular endothelial growth factor (VEGF) and Hepatocyte growth factor (HGF), which are critical for the growth, survival and differentiation of developing neurons.

The Company�� approach to treatment of neurodegenerative diseases with autologous adult stem cells includes a multi-step process beginning with harvesting of undifferentiated stem cells from the patient's own bone marrow, and concluding with transplantation of differentiated, neurotrophic factor-secreting mesenchymal stem cells (MSC-NTF) into the same patient-intrathecally and/or intramuscularly. Intrathecal (injection into the cerebrospinal fluid) transplantation consists of injection with a standard lumbar puncture; there is no need for a laminectomy -an invasive, orthopedic spine operation to remove a portion of the vertebral bone, as required by other technologies. Intramuscular (injection directly into muscle) transplantation is performed via a standard injection procedure as well. Its production process for induction of differentiation of human bone marrow derived mesenchymal stem cells into differentiated cells that produce NTF (MSC-NTF) for clinical use is conducted in full compliance with current Good Manufacturing Practice (cGMP).

Advisors' Opinion:
  • [By John Udovich]

    Small cap ALS and stem cell stock�Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) surged 22.68%�ahead if its Monday ice bucket challenge when they will release the final results from�a phase 2a clinical trial���meaning its worth taking a closer look at the stock along with the performance of stem cell stocks or ALS stocks like Cytokinetics, Inc (NASDAQ: CYTK), Neuralstem, Inc (NYSEMKT: CUR) and NeoStem Inc (NASDAQ: NBS). However, Brainstorm Cell Therapeutics does have a history of being the subject of paid promotions and/or investor relations activities when it was trading on the OTC.

Thursday, March 26, 2015

10 Best Industrial Disributor Stocks To Buy Right Now

10 Best Industrial Disributor Stocks To Buy Right Now: RLI Corp. (RLI)

RLI Corp., through its subsidiaries, underwrites property and casualty insurance primarily in the United States. The company operates in three segments: Casualty, Property, and Surety. The Casualty segment provides general liability services consisting of coverage for third party liability of commercial insurers, including manufacturers, contractors, apartments, and mercantile; commercial and personal umbrella coverage; and commercial transportation that include automobile liability and physical damage insurance to local, intermediate, and long haul truckers, public transportation risks, and equipment dealers, as well as incidental and related insurance coverage. It also offers professional liability coverages, such as directors? and officers? liability insurance, employment practices liability, and other miscellaneous professional liability coverage; and specialty program coverages, such as commercial property, general liability, inland marine, and crime, as well as deduc tible buy-back. The Property segment offers property coverage that consists primarily of excess and surplus lines and specialty insurance, such as fire and earthquake. It also provides insurance for commercial and industrial risks, such as office buildings, apartments, condominiums, and certain industrial and mercantile structures, as well as writes boiler and machinery coverage; marine coverage, including hull, cargo, and protection and indemnity; homeowners and dwelling fire insurance; and property facultative reinsurance for insurance companies. The Surety segment specializes in writing small-to-large commercial and small contract surety coverages, as well as for the energy, petrochemical, and refining industries. It offers miscellaneous bonds, such as license and permit, notary, and court bonds; and fidelity and crime coverage for commercial insured and select financial institutions. RLI Corp. was founded in 1965 and is headquartered in Peoria, Ill! inois.

Advisors' Opinion:
  • [By Neil Macneale]

    The top-rated stock among split announcements is RLI Corp. (RLI). I had never heard of this company, and I'm pleased to make its acquaintance.

  • [By Ben Levisohn]

    For the past several years, Berkshire has contrasted its own cost-free float provided by profitable underwriting against the industrys (unimpressive) tendency to lose money on underwriting while generating net returns from investment income. So far, so good. Less edifying, though, is the repeated contrast of Berkshires track record of profitability to State Farms…even though, as a mutual company, State Farms profitability goals are inherently different from for-profit insurers like Berkshire. Its true that through year-end 2013, Berkshires underwriters have now operated at an underwriting profit for eleven consecutive years, but so have ACE (ACE), American Financial (AFG), AmTrust Financial (AFSI), Arch Capital (ACGL), Chubb (CB), HCC (HCC), Progressive (PGR), RLI (RLI), and W.R. Berkley (WRB), any or all of whom provide a more meaningful comparison than contrasting Berkshires results to a company thats not out to produce a profit in t he first place.

  • source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/10-best-industrial-disributor-stocks-to-buy-right-now-2.html

Wednesday, March 25, 2015

Best Healthcare Technology Stocks To Buy For 2014

Like most investors, you probably aim for�the best possible return�when picking potential investments. But as consumers increasingly clamor for companies to�embrace social responsibility, good corporate citizenship is becoming a vital part of many companies' success. And it can boost the performance of our portfolios, too.

CR�magazine recently released its "100 Best Corporate Citizens"�list�for 2013, in which it rated members of the Russell 1000 large-cap index on 325 different elements related to responsible behavior. In the coming weeks, I'll delve into each of the seven categories that contribute to a company's overall score. Today, we'll look at the human rights category, which gets a 16% weighting. Here are the top-rated companies:

Gap (NYSE: GPS  )

Microsoft (NASDAQ: MSFT  )

Johnson Controls (NYSE: JCI  )

Johnson & Johnson (NYSE: JNJ  )

Northern Trust (NASDAQ: NTRS  )

Hot Building Product Stocks To Watch For 2015: EarthLink Inc.(ELNK)

EarthLink, Inc. provides communications services to individual and business customers in the United States. It operates in two segments, Consumer Services and Business Services. The Consumer Services segment offers Internet access and related value-added services. It provides dial-up Internet and narrowband access, broadband access, and voice-over-Internet-protocol services, as well as value-added services that include products for protection, communication, and performance, such as security products, premium email only, home networking, email storage, and Internet call waiting. This segment offer its products and services primarily through its call centers, search engine marketing, affinity marketing partners, resellers, and marketing alliances. The Business Services segment offers integrated communications services, such as secure IP-based networks, virtual private networks, Internet access, local telephone and long distance services, enhanced services, access trunks, pr ivate line services, asynchronous transfer mode/frame relay services, and mobile data and voice services, as well as installation, managed network, remote access, and disaster recovery services. It also provides wholesale services comprising broadband transport services, including private line, Ethernet private line, and wavelength services; local communications and local dial tone communications services; live and automated operator, and directory assistance services; and dedicated Internet access services and direct connectivity. In addition, this segment leases server space and provides Web hosting services that enable customers to build and maintain an online presence, including domain names, storage, mailboxes, software tools to build Web sites, e-commerce applications, and 24/7 customer support. This segment offers its services through direct sales, and independent dealers and sales agents. The company was founded in 1994 and is headquartered in Atlanta, Georgia.

Advisors' Opinion:
  • [By Geoff Gannon] nflation growth: Dun & Bradstreet (DNB)

    路 Inflation plus population growth: CEC Entertainment (CEC)

    路 Nominal GDP Growth: Village Supermarket (VLGEA)

    Over the last 10 years ��population growth, inflation, and real output per person growth has been so low it�� hard to tell the difference between companies growing at the rate of inflation, along with the population, or along with the economy.

    You have to squint really hard to see any difference in the revenue growth records of DNB, Chuck E. Cheese, and Village.

    This will not be true in all countries and at all times.

    A literally no growth company like Earthlink is actually shrinking. It just happens to look like it�� staying perfectly flat because inflation is hiding the company�� real decay rate. In real terms, the company has been shrinking by about 3% a year for the last 10 years. So, Earthlink is not a no growth company. It�� shrinking.

    That�� a bad sign. And, frankly, I don�� know how to value Earthlink. You would need to evaluate it as a turnaround or something ��not as a business that�� simplly stuck in place. I don�� know how to do that.

    So, Earhtlink goes into the ��oo hard��pile.

    Dun & Bradstreet and CEC Entertainment are actual no growth businesses. This is hidden by their constant share buy backs. So, if you look at their earnings per share growth they look kind of like Peter Lynch�� idea of a ��low growth��company or even a ��talwart�� They aren��. They��e no growth businesses.

    The same is pretty much true with Village Supermarket. Although this is complicated. The nature of their business ��high volume, low cost groceries ��means they can appear to be a no growth business when they are actually just keeping prices down and increasing volume. You would need to check their sales numbers more carefully. Grocery stores often discuss inflation in their annual reports. Village Supermarket always does t

  • [By Rich Duprey]

    Continuing its efforts to transform itself from a pure Internet service provider into an information technology company, EarthLink (NASDAQ: ELNK  ) announced Monday it is buying�cloud computing and hosted IT services provider CenterBeam for $22 million.�

Best Healthcare Technology Stocks To Buy For 2014: Eutelsat Communications SA (ETL)

Eutelsat Communications SA is a France-based holding company that provides fixed satellite services. It provides four types of services, including broadcast services, such as direct-to-home and professional broadcasting; broadband services, comprising broadband Internet access; telecoms and data services to ensure permanent communications links from all points of the globe, establish or restore communications in an emergency and multicast content; as well as mobile and maritime communications, such as fleet management and on- and off-shore broadband maritime communications. It operates a fleet of satellites covering Europe, the Middle East, North and sub-Saharan Africa, as well as parts of Asia and the Americas. In January 2014, it acquired Satelites Mexicanos, S.A. de C.V. and together with SES SA have completed the sale to EchoStar Corp. of Solaris Mobile Ltd. Advisors' Opinion:
  • [By Sofia Horta e Costa]

    Eutelsat Communications SA (ETL) declined 6.2 percent to 21.02 euros after predicting sales will grow by more than 2.5 percent for the year 2013 to 2014. The company, which operates 31 satellites, forecast growth of more than 5 percent for the following two years through June 2016. JPMorgan Chase & Co. cut its price target for the stock to 24 euros from 33 euros, saying analysts��will probably reduce their estimates following the company�� revised guidance.

Best Healthcare Technology Stocks To Buy For 2014: Oceaneering International Inc.(OII)

Oceaneering International, Inc., together with its subsidiaries, provides engineered products and services primarily to the offshore oil and gas industry with a focus on deepwater applications. The company?s Remotely Operated Vehicles segment provides submersible vehicles operated from the surface to support offshore oil and gas exploration, production, and construction activities. Its Subsea Products segment supplies various built-to-order specialty subsea hardware products. The company?s Subsea Projects segment provides multiservice vessels, oilfield diving, and support vessel operations, which are used primarily in inspection, repair, and maintenance and installation activities; and mobile offshore production systems. Its Inspection segment offers customers with a range of third-party inspection services to satisfy contractual structural specifications, internal safety standards, and regulatory requirements. The company?s Advanced Technologies segment offers project management, and engineering services and equipment for applications in non-oilfield markets. Oceaneering International, Inc. also serves defense and aerospace industries. It operates primarily in west Africa, Norway, the United Kingdom, Asia, Australia, Brazil, and the United States. The company was founded in 1965 and is based in Houston, Texas.

Advisors' Opinion:
  • [By Taylor Muckerman and Joel South]

    Oceaneering International (NYSE: OII  ) is a pure play on the deepwater space with its remotely operated vehicles and other subsea equipment. Both it and its similarly priced peer, FMC Technologies (NYSE: FTI  ) , compete for headlines tomorrow during earnings season. While guidance hasn't changed since last week, the market will almost certainly be looking for results on the high side or even expectation-beating numbers. What do Motley Fool analysts Joel South and Taylor Muckerman expect from these companies tomorrow?

  • [By Aaron Levitt]

    But given the company’s exposure, those hefty revenue and profit gains could be just for the beginning for SM Energy and SM stock investors. Meanwhile, its midcap size makes it perfect for a buyout.

    Midcap Energy Stocks To Buy #4: �Oceaneering International (OII)

    It takes a lot of technology and know-how in order to drill in the ultra-deep water of the world. For the energy stocks providing those services, it can mean some huge profits. For Remotely Operated Vehicles (ROVs) specialist Oceaneering International (OII), it can mean record profits.

Best Healthcare Technology Stocks To Buy For 2014: Celanese Corporation (CE)

Celanese Corporation, a technology and specialty materials company, engages in manufacture and sale of value-added chemicals, thermoplastic polymers, and other chemical-based products. It operates through four business segments: Advanced Engineered Materials, Consumer Specialties, Industrial Specialties, and Acetyl Intermediates. The Advanced Engineered Materials segment offers specialty polymers for application in automotive, medical, and electronics products, as well as other consumer and industrial applications. The Consumer Specialties segment provides cellulose acetate flake, film, and tow that are primarily used in filter products applications; Sunett, a sweetener; and food protection ingredients, such as sorbates and sorbic acid for the food, beverage, and pharmaceutical industries. The Industrial Specialties segment produces emulsions and ethylene vinyl acetate (EVA) performance polymers. Its emulsions products are used in applications, such as paints and coatings, adhesives, construction, glass fiber, textiles, and paper; and EVA performance polymers are used in flexible packaging films, lamination film products, hot melt adhesives, medical products, automotive, carpeting and photovoltaic cells. The Acetyl Intermediates segment offers acetyl products, including acetic acid, vinyl acetate monomer, acetic anhydride, and acetate esters for use as starting materials for colorants, paints, adhesives, coatings, and medicines. It also provides organic solvents and intermediates for pharmaceutical, agricultural, and chemical products. The company offers its products directly, as well as through distributors and electronic marketplaces in North America, Europe, Africa, the Asia-Pacific, and South America. Celanese Corporation was founded in 2004 and is headquartered in Dallas, Texas.

Advisors' Opinion:
  • [By Travis Hoium]

    What: Shares of chemical maker Celanese (NYSE: CE  ) jumped as much as 16% today after the company released earnings.

    So what: Revenue fell slightly in the first quarter, to $1.61 billion, but adjusted earnings per share jumped 44%, to $1.14. Revenue was in line with expectations, and earnings crushed the $0.79 that analysts expected.�

  • [By Marc Bastow]

    Chemical products manufacturer Celanese (CE) raised its quarterly dividend 39% to 25 cents per share payable payable on May 16 to shareholders of record May 5.
    CE Dividend Yield: 1.69%

  • [By Eric Volkman]

    Celanese (NYSE: CE  ) will have to pony up a significantly higher amount of money for its shareholder payouts. The company has declared a common stock dividend of $0.18 per share, to be paid on August 15 to shareholders of record as of August 5. That amount is exactly double the company's previous distribution of $0.09.

Best Healthcare Technology Stocks To Buy For 2014: Enersis S A(ENI)

Enersis S.A., an electric utility company, engages in the generation, transmission, and distribution of electricity in Chile, Argentina, Brazil, Colombia, and Peru. It owns and operates hydroelectric, thermal, and wind power plants. As of December 31, 2010, it had 14,833 megawatts of installed capacity with 195 power plants; and 13.3 million distribution customers covering approximately 50 million inhabitants. The company was formerly known as Compania Chilena Metropolitana de Distribucion Electrica S.A and changed its name to Enersis S.A. in August 1988. Enersis S.A. was founded in 1889 and is headquartered in Santiago, Chile. Enersis S.A. is a subsidiary of Endesa Latinoamerica S.A.

Advisors' Opinion:
  • [By Sofia Horta e Costa]

    European stocks were little changed at a one-week high as companies from Eni SpA (ENI) to Volkswagen AG posted profit that exceeded estimates, while a gauge of telecommunications companies retreated.

Best Healthcare Technology Stocks To Buy For 2014: Electro Scientific Industries Inc (ESIO)

Electro Scientific Industries, Inc. (ESI) incorporated on April 19, 1949, is a supplier of laser-based manufacturing solutions for the microtechnology industry. The Company operates high-technology manufacturing equipment, which consists of products that are organized in three groups: interconnect & microfabrication, semiconductor and components. The Company�� laser systems enable precise structuring of micron to submicron features in components and devices which are used in a wide variety of end products in the consumer electronics, computer, semiconductor, communications and other markets. Its laser microfabrication systems allow microelectronics, semiconductor, and other microtechnology manufacturers to physically alter select device features during high-volume production. In June 2012, it acquired Eolite Systems.

The Company�� laser-based systems improve production yields or enable improved performance for flexible and rigid high density interconnect printed circuit boards, semiconductor devices, light emitting diodes (LEDs), advanced semiconductor packaging, touch-panel glass, flat panel liquid crystal displays (LCDs) and other high value components. Additionally, it produces high-capacity test and inspection equipment that is critical to control process during the production of multilayer ceramic capacitors (MLCCs). Its equipment ensures that each component meets the electrical and physical tolerances required to perform properly. Lastly, it produces systems that use photonic technology to perform precision inspection for control and defect identification. The Company�� Interconnect & Microfabrication Group products address an expanding number of applications and materials on a broad set of substrates, including panels, continuous-feed reels, and discrete three dimensional components or devices.

Interconnect Via Drilling

For electrical interconnect applications, The Company�� laser via micro fabrication systems target applications that require the ! highest accuracy and smallest via (hole) dimensions to create electrical connections between layers in flexible circuits, high-density circuit boards and IC packages. The Company�� microvia drilling technology addresses the rapidly changing applications in IC packages, multichip modules and HDI circuit boards. Its ultraviolet (UV) laser processing systems employ technology in lasers, optics and motion control.

Advanced Microfabrication

The Company offers several platforms that enable customers to perform precision drilling, scribing, cutting, etching, routing or marking on many different types of materials and devices including glass, metal, plastic, paint and ceramics. It also offer laser ablation systems that ablate material for identification and analysis applications, including forensics, mineral analysis and research.

Semiconductor Group (SG)

The Company�� Semiconductor Group products address multiple applications that utilize laser energy to process materials on wafer-based substrates. This includes traditional silicon wafers, LEDs wafers, and new ultrathin silicon wafers used in the three-dimensional (3D) packaging applications. Semiconductor Memory Yield Improvement Systems includes semiconductor memory yield improvement products are designed to cost-effectively enable post-repair yield improvements in the manufacturing of dynamic random access memory (DRAM) memory devices.

3D Semiconductor Wafer Processing

The 3D chip packaging technologies is driving the need for silicon wafers to become thinner in order to allow for stacking of wafers within the same packaging geometry. As wafers become thinner, they become more challenging to cut into discrete chips using traditional mechanical saws. The Company�� model 9900 uses a laser to dice ultra-thin silicon wafers, those with a thickness of 50 microns or below, and to singulate interposers. In addition, this platform can be used to scribe next generation thin film ! materials! that lend themselves to laser processing.

LED Wafer Scribing

The Company�� AccuScribe line of sapphire wafer scribing systems is a key component in the manufacture of LEDs. During production, LEDs are created on a thin wafer of synthetic sapphire crystal that must be broken into individual units at the end of the process. The brittle nature of the sapphire wafer requires that it be carefully cut in order to prevent unwanted fractures, yield losses, and lower light output when the wafer is broken apart into discrete LEDs. The AccuScribe systems use a laser to scribe the wafer with a precise groove between individual LEDs. When mechanical force is applied to the wafer, it fractures along these grooves and allows the wafer to be split apart into discrete LEDs. These systems are capable of scribing both standard and high brightness designs for general illumination applications. In addition, this platform can be used to address singulation of various LED packaging materials.

LCD Repair

The Comapny's laser LCD repair systems are critical to improving yields in the manufacture of flat panel displays. During production, individual pixels of a display may develop electrical defects that result in no light emission or the emission of only a steady white light. To correct these defects, flat panel display producers employ a laser repair process to isolate the electrical defects during production by cutting the inputs to the pixel. Its laser systems are primarily sold to the manufacturers of LCD repair tools as a key component of their products.

Semiconductor Systems

The products include industry wafer marking equipment, wafer and circuit trim tools, and LCD repair tools. Wafer marking equipment is used for serialization and wafer identification by both manufacturers of semiconductor wafers and within semiconductor fabs. Wafer and circuit trim tools are laser systems that adjust the electrical performance of semiconductor devic! es or hyb! rid circuits by removing a precise amount of material from one or more circuit components.

Components Group (CG)

The Company designs and manufactures products that combine high-speed small parts handling technology with real-time control systems to provide automated, cost-effective inspection solutions for manufacturers of MLCC and other passive components such as capacitor arrays, inductors, resistors, varistors and hybrid circuits. These components, produced in quantities of trillions of units per year, process analog, digital and high-frequency signals and are used in all electronic products.

The Company provides several types of products and solutions in this market. Its MLCC test systems employ high-speed handling and positioning techniques to precisely load, test and sort MLCCs based on their electrical energy storage capacity, or capacitance, and their electrical energy leakage, or dissipation factor. Its 35XX series is the productive tester. Its 3510 model enables high speed testing of the industry�� smallest metric 0402 capacitors used primarily in advanced cell phone and tablet designs. It also produces consumable products, such as carrier plates and termination belts, both of which are used to hold MLCCs during the manufacturing and testing process.

The Company competes with Mechanics, Ltd., LPKF Laser & Electronics AG, Mitsubishi Electric Corporation, Orbotech Ltd., InnoLas Systems GmbH, DISCO Corporation, Laser Solutions, Inc., Quantel USA, Inc., Humo Laboratory, Ltd. and HOYA Corporation.

Advisors' Opinion:
  • [By Evan Niu, CFA]

    What: Shares of Electro Scientific (NASDAQ: ESIO  ) popped briefly today, up by 11% at the high, after the company reported earnings.

    So what: Revenue in the fiscal fourth quarter totaled $39.6 million, which translated into a non-GAAP net loss of $1 million, or $0.03 per share. Both figures came out better than expected, as consensus estimates were calling for $38.1 million in revenue and an adjusted loss of $0.07 per share.

  • [By Eric Volkman]

    Electro Scientific Industries (NASDAQ: ESIO  ) has a new division under its corporate wing. The company has inked a definitive agreement to purchase the semiconductor systems unit of GSI Group (NASDAQ: GSIG  ) . The terms of the deal were not disclosed.

Best Healthcare Technology Stocks To Buy For 2014: Clifton Savings Bancorp Inc.(CSBK)

Clifton Savings Bancorp, Inc. operates as the holding company for Clifton Savings Bank that provides various financial services to consumers and businesses in northeast New Jersey. It offers liquid and term deposit instruments, such as free checking accounts, business checking accounts, negotiable order of withdrawal accounts, high yield checking accounts, money market accounts, passbook and statement savings accounts, and club and certificates of deposit. The company?s loan portfolio includes one to four-family residential loans; multi-family and commercial real estate loans; residential construction loans; and consumer loans, including second mortgage loans, loans secured by passbook or certificate accounts, and home equity lines of credit. It operates 12 full-service banking offices. The company was founded in 1928 and is headquartered in Clifton, New Jersey. Clifton Savings Bancorp, Inc. is a subsidiary of Clifton MHC.

Advisors' Opinion:
  • [By Monica Gerson]

    Clifton Bancorp (NASDAQ: CSBK) shares dropped 10.32% to $11.65 after the company announced stock offering results.

    Response Genetics (NASDAQ: RGDX) slipped 9.47% to $1.34 after the company reported Q4 results. The company posted a quarterly net loss of $3.2 million, or $0.09 per share, versus a year-ago net loss of $0.5 million, or $0.01 per share.